密苏里州乳腺癌筛查法律变化与筛查率及数字乳腺断层合成使用的关系
该回顾性研究利用2015-2022年全国理赔数据库,采用双重差分法分析密苏里州扩大乳腺X线筛查覆盖范围(从50岁起每两年一次改为40岁起每年一次)与筛查率及数字乳腺断层合成(DBT)使用的关系。结果显示,法律变化后医疗补助和商业保险女性筛查可能性增加高于联邦法律规定的 Medicare Advantage 女性,医疗补助女性接受DBT的可能性也更高。
要点
- 密苏里州法律扩大筛查覆盖后,医疗补助女性筛查可能性增加高于 Medicare Advantage 女性(OR 1.45)。
- 商业保险女性筛查可能性增加亦高于 Medicare Advantage 女性(OR 1.05)。
- 已筛查的医疗补助女性接受DBT可能性在州内比较中更高(OR 2.31)。
核心结论
- 密苏里州扩大乳腺癌筛查覆盖的法律变化与医疗补助患者筛查率增加及已筛查患者(医疗补助和商业保险)接受DBT可能性增加强烈相关。
研究设计与样本
- 回顾性研究(2015-2022年),使用全国理赔数据库(Inovalon Insights, LLC),纳入1,008,881名唯一女性(41.4%即417,835名在密苏里州),采用双重差分法逻辑回归模型比较密苏里州内医疗补助和商业保险患者与联邦监管的 Medicare Advantage 计划受益人,并与无覆盖变化的密苏里州边境州患者比较。
诊断标准与关键数值
- 法律变化后,医疗补助女性筛查乳腺X线摄影可能性增加高于 Medicare Advantage 女性(OR 1.45;95%CI 1.36-1.55)。
- 法律变化后,商业保险女性筛查乳腺X线摄影可能性增加高于 Medicare Advantage 女性(OR 1.05;95%CI 1.01-1.10)。
- 已筛查的医疗补助女性接受DBT可能性在州内比较中更高(OR 2.31;95%CI 2.01-2.66),在边境州比较中亦更高(OR 1.24;95%CI 1.22-1.27)。
- 已筛查的商业保险女性接受DBT可能性 likewise 相对增加。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To estimate the association of Missouri law changes expanding mammography coverage to include annual screening from age 40 (previously biennial from age 50), digital breast tomosynthesis (DBT) on overall screening rates, and use of DBT.
METHODS: This retrospective study (2015-2022) used a national claims database (Inovalon Insights, LLC). A difference-in-differences approach was used in logistic regression models to assess the association of changes in Missouri law with women's likelihood of screening, and for those screened, the likelihood of receiving DBT. Within-Missouri models compared Medicaid and commercial patients to beneficiaries of federally regulated Medicare Advantage (MA) plans. The association was further tested via a comparison of Missouri patients to their counterparts in Missouri border states without a coverage change.
RESULTS: There were 1,008,881 unique women (41.4% [417,835] in Missouri). After the Missouri law change, women with Medicaid (odds ratio [OR]: 1.45; 95% confidence interval [CI]: 1.36-1.55) and commercial insurance (OR: 1.05; 95% CI: 1.01-1.10) had a greater increase in likelihood of screening mammography compared to MA women whose coverage is based on federal law. Medicaid women with mammography had a higher likelihood of DBT for both within-Missouri (OR: 2.31; 95% CI: 2.01-2.66) and border-state (OR: 1.24; 95% CI: 1.22-1.27) comparisons. Commercially insured women likewise had a relative increase in likelihood of receiving DBT.
CONCLUSION: Changes in Missouri law expanding breast cancer screening coverage were strongly associated with increased screening rates among Medicaid patients as well as increased likelihood of DBT among screened patients, for both Medicaid and commercially insured patients.
引用
- Patel AK, Drake AR, Brandt E, et al. Association of Changes in Missouri Law for Breast Cancer Screening, Screening Rates, and Use of Digital Breast Tomosynthesis. J Am Coll Radiol. 2025. PMID: 40704963. doi:10.1016/j.jacr.2025.06.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。